Cytokinetics (CYTK)

Cytokinetics (CYTK) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CYTK last traded at $62.86, -0.21% on the day.
• Cytokinetics: market cap $8.76B, P/E -8.8, revenue $70.96M over the last four quarters, next earnings 2026-11-04.
• Over the past year CYTK returned 0.98%; year to date -1.07%.

Updated 2026-11-02 18:25 UTC